Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
OCUL
OCUL News & Events
-
Add to Watchlist
Trade OCUL Autonomously
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
OCUL News
Ocular Therapeutix Updates on AXPAXLI Drug Progress
Jun 22 2026
NASDAQ.COM
Ocular Therapeutix Files NDA for Axpaxli, Plans Streamlined Trials
Jun 17 2026
stocktwits
Ocular Plans to Submit AXPAXLI NDA Application
Jun 17 2026
Newsfilter
Ocular Therapeutix Reaches NDA Agreement with FDA for Axpaxli Submission
Jun 17 2026
seekingalpha
Investment Comparison: Ocular Therapeutix vs. Prime Medicine
Jun 15 2026
Fool
Investment Choices: Ocular Therapeutix vs. Prime Medicine
Jun 15 2026
NASDAQ.COM
Ocular Therapeutix to Participate in Clinical Trials at Summit 2026
Jun 04 2026
Newsfilter
Acuta Capital Reduces Stake in Ocular Therapeutix Significantly
May 26 2026
Fool
Show More News
OCUL Events
No data
OCUL Monitor News
Ocular Therapeutix to Submit NDA for AXPAXLI in Q4 2026
Jun 17 2026
Ocular Therapeutix shares rise despite broader market decline
Mar 02 2026
Ocular Therapeutix Faces Stock Decline Amid Market Weakness
Feb 17 2026
Ocular Therapeutix Stock Surges After Rejecting Sanofi's Bid
Jan 15 2026
Ocular Therapeutix Inc Surges After NDA Submission Announcement
Dec 08 2025
OCUL Earnings Analysis
Ocular Therapeutix Inc Reports Third Quarter 2024 Financial Results
1 years ago
People Also Watch
